Mental health disorders in patients with end-stage renal failure

Maria Karastathi-Asimakopoulou; Anna Loudovikou

doi:10.56508/mhgcj.v5i2.146

Authors

Maria Karastathi-Asimakopoulou University of Crete
Anna Loudovikou Aristotle University of Thessaloniki https://orcid.org/0000-0002-5339-1688

DOI:

https://doi.org/10.56508/mhgcj.v5i2.146

Keywords:

mental health, kidney failure, anxiety, depression

Abstract

Renal failure is commonly accompanied by psychological distress compounding to mental health conditions such as anxiety and depression. Common risk factors towards the development of mental health disorders in people with renal failure include the need to attend regular hemodialysis session and the burden of related complications. A growing body of evidence has elucidated the biochemical and immunological underpinnings of mental health disorders in the context of renal failure. This knowledge calls for strengthening the existing mental health support frameworks and conducting research with the reported molecular pathways as potential therapeutic targets

Author Biographies

Maria Karastathi-Asimakopoulou, University of Crete

Faculty of Medicine

Anna Loudovikou, Aristotle University of Thessaloniki

School of Philosophy

References

Goh ZS, Griva K (2018) Anxiety and depression in patients with end-stage renal disease: Impact and management challenges: A narrative review. Int J Nephrol Renovasc Dis. 11:93–102. DOI: https://doi.org/10.2147/IJNRD.S126615

Stavropoulou A, Grammatikopoulou MG, Rovithis M, Kyriakidi K, Pylarinou A, Markaki AG (2017) Through the patients' eyes: The experience of end-stage renal disease patients concerning the provided nursing care. Healthcare. 5:1–11. DOI: https://doi.org/10.3390/healthcare5030036

Kamimura MA, Draibe SA, Dalboni MA,(2007) Serum and cellular interleukin-6 in hemodialysis patients: Relationship with energy expenditure. Nephrol Dial Transplant.22:839–844. DOI: https://doi.org/10.1093/ndt/gfl705

Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA(1994). Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int. 45:890–896. DOI: https://doi.org/10.1038/ki.1994.117

Cappelli G, DiFelice A, Perrone S,(1998). Which level of cytokine production is critical in hemodialysis? Nephrol Dial Transplant.13:55–60. DOI: https://doi.org/10.1093/ndt/13.suppl_7.55

Chen Y, Wu S, Wang S. (2003) Depression in chronic hemodialysed patients. Nephrology.8:121–6. DOI: https://doi.org/10.1046/j.1440-1797.2003.00147.x

Palmer, S., Vecchio, M., Craig, J. C., Tonelli, M., Johnson, D. W., Nicolucci, A., et al. (2013). Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 84, 179–191. doi: 10.1038/ki.2013.77 DOI: https://doi.org/10.1038/ki.2013.77

Hirotsu, C., Tufik, S., Ribeiro, D. A., Alvarenga, T. A., Andersen, M. L. (2011). Genomic damage in the progression of chronic kidney disease in rats. Brain Behav. Immun. 25, 416–422. doi: 10.1016/j.bbi.2010.10.021 DOI: https://doi.org/10.1016/j.bbi.2010.10.021

Dantzer R. (2004) Cytokine-induced sickness behaviour: A neuroimmune response to activation of innate immunity. Eur J Pharmacol. 500:399–411. DOI: https://doi.org/10.1016/j.ejphar.2004.07.040

Panagiotakos DB, Pitsavos C, Chrysohoou C, (2004) Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J. 25:492–499. DOI: https://doi.org/10.1016/j.ehj.2004.01.018

Heimburger O, Qureshi AR, Blaner WS, Berglund L, Stenvinkel P. (2000) Hand-grip muscle strength, lean body mass and plasma proteins as marker of nutritional status in patients with chronic renal failure close to start to dialysis therapy. Am J Kidney Dis. 6:1213–1225. DOI: https://doi.org/10.1053/ajkd.2000.19837

Friedman AN, Fadem SZ. (2010) Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol 21: 223–230 DOI: https://doi.org/10.1681/ASN.2009020213

Sedaghat, S., Cremers, L. G., De Groot, M., Hoorn, E. J., Hofman, A., Van Der Lugt, A., et al. (2015). Kidney function and microstructural integrity of brain white matter. Neurology 85, 154–161. doi: 10.1212/WNL.0000000000001741 DOI: https://doi.org/10.1212/WNL.0000000000001741

Tamura, M. K., Pajewski, N. M., Bryan, R. N., Weiner, D. E., Diamond, M., Van Buren, P., et al. (2016). Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adults.Neurology 86, 1208–1216. doi: 10.1212/WNL.0000000000002527 DOI: https://doi.org/10.1212/WNL.0000000000002527

Reger,M. A.,Stanley,I. H., &Joiner,T. E.(2020).Suicide mortality and coronavirus disease 2019-a perfect storm?JAMA Psychiatry. Advance online publication. doi:10.1001/jamapsychiatry.2020.1060 DOI: https://doi.org/10.1001/jamapsychiatry.2020.1060

Romash, I. (2020). The nature of the manifestation of procrastination, level of anxiety and depression in medical students in a period of altered psycho-emotional state during forced social distancing because of pandemic COVID-19 and its impact on academic performance. Mental Health: Global Challenges Journal, 3(2), 6–11. https://doi.org/10.32437/mhgcj.v4i2.92 DOI: https://doi.org/10.32437/mhgcj.v4i2.92

Romash, I., Neyko, V., Romash, I., Vynnyk, M., Gerych, O., & Pustovoyt, M. (2022). The nature of the manifestation of procrastination among medical university teachers during the piriod of altered psycho-emotional state during forsed social distancing due to the COVID-19 pandemic and its impact on the quality of life. Scientific Studios on Social and Political Psychology, (49(52). https://doi.org/10.33120/sssppj.vi49(52).267 DOI: https://doi.org/10.33120/sssppj.vi49(52).267

Rayan, R.A., Zafar, I. and Romash, I.B. (2021). Healthcare System 4.0 Perspectives on COVID-19 Pandemic. In Enabling Healthcare 4.0 for Pandemics (eds A. Juneja, V. Bali, S. Juneja, V. Jain and P. Tyagi). https://doi.org/10.1002/9781119769088.ch2 DOI: https://doi.org/10.1002/9781119769088.ch2